TGFB1 and neoplasm: Angiogenesis is a hallmark of malignant tumors, and together with hypoxia, TGF-β could be an important factor driving vascular network enhancement as well as the exhaustion of anti-tumor cytotoxic cells and NK cell dysfunction [149–153].